These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 19635537)

  • 21. Self nanoemulsifying drug delivery system (SNEDDS) of rosuvastatin calcium: design, formulation, bioavailability and pharmacokinetic evaluation.
    Balakumar K; Raghavan CV; selvan NT; prasad RH; Abdu S
    Colloids Surf B Biointerfaces; 2013 Dec; 112():337-43. PubMed ID: 24012665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and characterization of self-nanoemulsifying drug delivery systems (SNEDDS) of atorvastatin calcium.
    Mantri SK; Pashikanti S; Murthy KV
    Curr Drug Deliv; 2012 Mar; 9(2):182-96. PubMed ID: 22283646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
    Cirri M; Mura P; Mora PC
    Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-nanoemulsifying drug-delivery system for improved oral bioavailability of rosuvastatin using natural oil antihyperlipdemic.
    Abo Enin HA
    Drug Dev Ind Pharm; 2015; 41(7):1047-56. PubMed ID: 25404208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation by design of felodipine loaded liquid and solid self nanoemulsifying drug delivery systems using Box-Behnken design.
    Verma S; Singh SK; Verma PR; Ahsan MN
    Drug Dev Ind Pharm; 2014 Oct; 40(10):1358-70. PubMed ID: 23879216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixed surfactant based (SNEDDS) self-nanoemulsifying drug delivery system presenting efavirenz for enhancement of oral bioavailability.
    Senapati PC; Sahoo SK; Sahu AN
    Biomed Pharmacother; 2016 May; 80():42-51. PubMed ID: 27133038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential.
    Singh B; Khurana L; Bandyopadhyay S; Kapil R; Katare OO
    Drug Deliv; 2011 Nov; 18(8):599-612. PubMed ID: 22008038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies.
    Zhao Y; Wang C; Chow AH; Ren K; Gong T; Zhang Z; Zheng Y
    Int J Pharm; 2010 Jan; 383(1-2):170-7. PubMed ID: 19732813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and in vitro-in vivo evaluation of Witepsol H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q(10).
    Nepal PR; Han HK; Choi HK
    Eur J Pharm Sci; 2010 Feb; 39(4):224-32. PubMed ID: 20035865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin.
    Zhang P; Liu Y; Feng N; Xu J
    Int J Pharm; 2008 May; 355(1-2):269-76. PubMed ID: 18242895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems.
    Balakrishnan P; Lee BJ; Oh DH; Kim JO; Lee YI; Kim DD; Jee JP; Lee YB; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2009 Jun; 374(1-2):66-72. PubMed ID: 19446761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect.
    Miao Y; Chen G; Ren L; Pingkai O
    Drug Deliv; 2016 Sep; 23(7):2163-2172. PubMed ID: 25148542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation of solid self-nanoemulsifying drug delivery systems using N-methyl pyrrolidone as cosolvent.
    Agrawal AG; Kumar A; Gide PS
    Drug Dev Ind Pharm; 2015 Apr; 41(4):594-604. PubMed ID: 24517575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uptake of phenothiazines by the harvested chylomicrons ex vivo model: influence of self-nanoemulsifying formulation design.
    Shahnaz G; Hartl M; Barthelmes J; Leithner K; Sarti F; Hintzen F; Rahmat D; Salvenmoser W; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2011 Sep; 79(1):171-80. PubMed ID: 21303694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine.
    Cui SX; Nie SF; Li L; Wang CG; Pan WS; Sun JP
    Drug Dev Ind Pharm; 2009 May; 35(5):603-11. PubMed ID: 19040178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate.
    Paliwal R; Paliwal SR; Mishra N; Mehta A; Vyas SP
    Int J Pharm; 2009 Oct; 380(1-2):181-8. PubMed ID: 19576973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and characterization of self-microemulsifying drug delivery system of tacrolimus for intravenous administration.
    Borhade VB; Nair HA; Hegde DD
    Drug Dev Ind Pharm; 2009 May; 35(5):619-30. PubMed ID: 18979309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and bioavailability assessment of ramipril nanoemulsion formulation.
    Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M
    Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal.
    Elsheikh MA; Elnaggar YS; Gohar EY; Abdallah OY
    Int J Nanomedicine; 2012; 7():3787-802. PubMed ID: 22888234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies.
    Singh G; Pai RS
    Drug Deliv; 2015; 22(4):522-30. PubMed ID: 24512464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.